Antidiabetics Market to grow at 10.5% CAGR from 2017 to 2024

1
Antidiabetics Market share to witness growth of
10.5 from 2017 to 2024 Global Market Insights
Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Antidiabetics Market

• Antidiabetics Market growth is driven by rising
  geriatric population base, innovation of new
  drugs, increasing adoption of drugs and increased
  disposable income.
• Antidiabetics Market size is set to reach USD 110
  billion by 2024 according to a new research
  report by Global Market Insights, Inc.
• Increasing number of obese and diabetic patients
  coupled with rising patient awareness levels
  serve as high impact rendering factors for
  antidiabetic market growth over the forecast
  period.
• Favorable government initiatives such as Diabetes
  Prevention Program (DPP) that aims to help
  individuals with prediabetes, reduces their risk
  to develop type 2 diabetes.
• Basal insulin suppresses hepatic gluconeogenesis
  and prevent increase in glucose level during
  fasting state in insulin-deficient patients.
• Biguanides should contribute for significant
  revenue share in 2016. It is colorless solid and
  prevents production of glucose in liver.

3
Continued...

• It helps in improving sensitivity of body towards
  insulin and decreases amount of sugar absorbed in
  intestines and will increase demand for such
  antidiabetic drugs.
• U.S. antidiabetics market size valued over USD
  19.4 billion in 2016 and expected to grow
  significantly over the coming years.
• UK contributed for significant revenue share in
  2016. The growth is attributed due to wide range
  of funds offered by Diabetes UK for research
  related to the treatment of diabetes and its
  complications.
• Japan antidiabetics market should grow at
  significant rate over the forecast period.
  Diabetic population is on rise due to lifestyle
  changes that will accompany economic growth and
  drive antidiabetic market growth.
• Some of the companies operating in antidiabetics
  market include Eli Lilly, Pfizer, Novo Nordisk,
  Takeda Pharmaceuticals, Sanofi Aventis, Merck,
  Boehringer Ingelheim and Oramed Pharmaceuticals.

4
India Antidiabetics Market, By Product, 2013 -
2024 (USD Million)

5

Browse Full Market Research Report On
Antidiabetics Market _at_ http//bit.ly/2zArLIV
Request for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/504 https//www.gminsights.com/request-sample/det
ail/49
6
360 Analysis

• Product Analysis
• Insulin products accounted for largest market
  share in 2016 and is anticipated to expand at
  approximately 12.0 CAGR over the coming years.
  Major dominant players are developing innovative
  products used to treat and prevent the disease
  owing to increased burden of diabetes.
• Regional Analysis
• U.S. antidiabetics market accounted for largest
  regional share in 2016 owing to high prevalence
  of diabetes in the country. Germany antidiabetics
  market will witness a robust growth over the
  forecast period due to rising prevalence of type
  II diabetes which further results to increased
  usage rate of antidiabetics in the country. Asia
  Pacific should witness lucrative growth over the
  forecast timeframe owing to the presence of large
  patient pool in India and China.
• Competitive Market Share
• Some of the major players dominating global
  antidiabetics market are Novo Nordisk, Eli Lilly
  and Sanofi. Other active players in the market
  include Takeda Pharmaceuticals, Merck, Boehringer
  Ingelheim and Bristol-Myers Squibb.

7
Stay In Touch Website www.gminsights.com Soci
al Media